In the Health Policy Podcast episode featuring Wayne Winegarden from the Pacific Research Institute, the discussion centers on the 340B Drug Pricing Program. Winegarden critiques the program’s lack of transparency and its unintended consequences, which have led to large hospital systems profiting at the expense of smaller institutions and patients. He advocates for reforms, including improved transparency and a shift in funding models to better serve the intended vulnerable populations.
Listen to Wayne Winegarden on the Health Policy Podcast: The $100 Billion Loophole: Why 340B Reform is Essential
Related Posts
The federal tax-credit scholarship that runs without federal cash
The Educational Choice for Children Act (ECCA) represents a major shift in how…
Technological tools should never undermine the foundational principles of a free society
Conservatives Must Reclaim the Fourth Amendment from Mass Surveillance Every…
Illinois checks, balances? Not under Pritzker
As veto session begins and power goes back to the Democratic majority…
House Bill 718 — Denturity, renewal fee (-1)
Bill Description: House Bill 718 would increase occupational licensing fee caps…
The Administrative State Strikes Back?
In February, after the U.S. Supreme Court declared that the White House acted…
Benjamin Franklin and the Birth of American Liberty—11/21 Virtual Event
Benjamin Franklin—statesman, inventor, and journalist—stands among the great…
Colorado Tax Bracket Creep – Independence Institute
Did you know we have a news site? At Complete Colorado, we aggregate the most…
New federal tool brings transparency to union spending
The U.S. Department of Labor has launched a new tool designed to make union…
The high cost of finding breast cancer too late
Using Medicare data on cancer patients aged 66 and older, researchers calculated…
57% of Chicago’s payroll spending goes to pension debt
A history of financial mismanagement has left the city putting in 57% of…












